Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 25 May 2007. doi:10.1136/thx.2006.074641
Thorax 2007;62:1074-1080
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
thx.2006.074641v1
62/12/1074    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilliard, T. N
Right arrow Articles by Davies, J. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilliard, T. N
Right arrow Articles by Davies, J. C

CYSTIC FIBROSIS

Airway remodelling in children with cystic fibrosis

Tom N Hilliard1, Nicolas Regamey1, Janis K Shute2, Andrew G Nicholson3, Eric W F W Alton1, Andrew Bush4, Jane C Davies1

1 Department of Gene Therapy, National Heart and Lung Institute, Imperial College, London, UK
2 Institute of Biomedical and Biomolecular Sciences, University of Portsmouth, Portsmouth, UK
3 Department of Histopathology, Royal Brompton Hospital, London, UK
4 Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK

Correspondence to:
Dr Tom Hilliard, Department of Paediatric Respiratory Medicine, Royal Hospital for Children, Bristol BS2 8BJ, UK; tom.hilliard{at}ubht.nhs.uk

Background: The relationship between airway structural changes and inflammation is unclear in early cystic fibrosis (CF) lung disease. A study was undertaken to determine changes in airway remodelling in children with CF compared with appropriate disease and healthy controls.

Methods: Bronchoalveolar lavage and endobronchial biopsy were performed in a cross-sectional study of 43 children with CF (aged 0.3–16.8 years), 7 children with primary ciliary dyskinesia (PCD), 26 with chronic respiratory symptoms (CRS) investigated for recurrent infection and/or cough and 7 control children with no lower airway symptoms. Inflammatory cells, cytokines, proteases and matrix constituents were measured in bronchoalveolar lavage fluid (BALF). Reticular basement membrane (RBM) thickness was measured on biopsy specimens using light microscopy.

Results: Increased concentrations of elastin, glycosaminoglycans and collagen were found in BALF from children with CF compared with the CRS group and controls, each correlating positively with age, neutrophil count and proteases (elastase activity and matrix metalloproteinase-9 (MMP-9) concentration). There were significant negative correlations between certain of these and pulmonary function (forced expiratory volume in 1 s) in the CF group (elastin: r = –0.45, p<0.05; MMP-9:TIMP-1 ratio: r = –0.47, p<0.05). Median RBM thickness was greater in the CF group than in the controls (5.9 µm vs 4.0 µm, p<0.01) and correlated positively with levels of transforming growth factor-β1 (TGF-β1; r = 0.53, p = 0.01), although not with other inflammatory markers or pulmonary function.

Conclusions: This study provides evidence for two forms of airway remodelling in children with CF: (1) matrix breakdown, related to inflammation, proteolysis and impaired pulmonary function, and (2) RBM thickening, related to TGF-β1 concentration but independent of other markers of inflammation.


Abbreviations: BALF, bronchoalveolar lavage fluid; CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane regulator; CRS, chronic respiratory symptoms; FEV1, forced expiratory volume in 1 s; IL, interleukin; MMP, matrix metalloproteinase; NE, neutrophil elastase; PCD, primary ciliary dyskinesia; RBM, reticular basement membrane; TGF-β1, transforming growth factor-β1; TIMP-1, tissue inhibitor of metalloproteinases-1




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
B. M. Linnane, G. L. Hall, G. Nolan, S. Brennan, S. M. Stick, P. D. Sly, C. F. Robertson, P. J. Robinson, P. J. Franklin, S. W. Turner, et al.
Lung Function in Infants with Cystic Fibrosis Diagnosed by Newborn Screening
Am. J. Respir. Crit. Care Med., December 15, 2008; 178(12): 1238 - 1244.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
Paediatric lung disease
Thorax, December 1, 2008; 63(Suppl_7): A32 - A35.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Regamey, M. Ochs, T. N. Hilliard, C. Muhlfeld, N. Cornish, L. Fleming, S. Saglani, E. W. F. W. Alton, A. Bush, P. K. Jeffery, et al.
Increased Airway Smooth Muscle Mass in Children with Asthma, Cystic Fibrosis, and Non-Cystic Fibrosis Bronchiectasis
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 837 - 843.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in Pediatric Lung Disease 2007
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 686 - 695.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society